IO Biotech Inc

NASDAQ IOBT

Data sourced from iex and EODHD
Download Data

IO Biotech Inc Income Statement 2020 - 2024

This table shows the Income Statement for IO Biotech Inc going from 2020 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-03-31
Revenue
M 0 1 0 0 0 0 0 0 0 0 0 0 0 0 - -
Cost of Revenue
M 0 0 0 0 0 0 - - - - - - - - - -
Gross Profit
M 0 1 0 0 0 0 - - - - - - - - - -
Operating Expenses
M 20 29 23 22 18 20 - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 6 6 6 5 6 6 6 6 7 5 3 2 1 0 1 -
Research and Development (R&D) Expenses
M 14 22 18 17 12 14 10 12 10 16 4 7 3 2 3 -
Other Operating Expenses
M 0 1 0 0 0 0 - - - - - - - - - -
Costs and Expenses
M 20 28 23 22 18 20 - - - - - - - - - -
Operating Income
M -20 -28 -23 -22 -18 -20 -16 -18 -17 -21 -7 -9 -4 -3 -3 -
Interest Expense
M - 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 -
Non-operating Income/Expense
M 1 2 0 0 1 1 0 0 0 0 3 -29 0 0 0 -
EBT
M -19 -26 -22 -21 -17 -19 -16 -18 -17 -21 -4 -38 -4 -3 -3 -
Income Tax Provision
M 0 0 0 1 0 1 0 0 0 0 0 0 - 0 0 -
Income after Tax
M -19 -26 -22 -21 -17 -20 -16 -18 -17 -21 -5 -38 - -3 -3 -
Non-Controlling Interest
M - - 0 0 0 0 0 0 0 1 2 -20 2 - - -
Net Income
M - - -22 -21 -17 -20 -16 -18 -17 -22 -7 -21 -6 - -4 -4
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 65,880,914.00 65,880,914.00 50,168,303.00 28,815,267.00 28,815,267.00 28,815,267.00 28,815,267.00 28,815,267.00 28,815,267.00 25,727,244.00 25,727,244.00 11,548,198.00 11,548,198.00 11,548,198.00 11,548,198.00 -
EBITDA
M -20 -28 -22 -20 -17 -20 -15 -18 -17 -21 -4 -38 -4 -3 -3 -
Depreciation and Amortization
M 0 0 2 0 1 1 1 0 0 -49 3 -29 - 0 0 -
EBIT
M -20 -28 -23 -21 -18 -20 -16 -18 -17 28 -7 -9 -4 -3 -3 -2
Income from Discontinued Operations
M - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -2.18 -1.37 1.98 -2.58 -2.44 -5.17 -0.74 -0.57 -0.39 -0.32 -1.50 -0.19 - -0.43 -0.20 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0 0 0 0 0 0 0 - 0 -
Gross Profit Margin
% - 81.89 - - - - - - - - - - - - - -
Operating Income Margin
% - -2,539.01 - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - -
EBITDA Ratio
% - -2,520.90 - - - - - - - - - - - - - -
EBIT Ratio
% - -2,539.01 - - - - - - - - - - - - - -
EBT Ratio
% - -2,326.94 - - - - - - - - - - - - - -

StockViz Staff

September 8, 2024

Any question? Send us an email